CD8A and cancer: So we used immunofluorescence to evaluate CD8 expression in tumor tissues after treatment with NS, DOX, HA-b-PCDA NPs, or DOX/HA-b-PCDA NPs, to preliminarily investigate the potential anti-cancer immunity effect of DOX/HA-b-PCDA NPs.